- Revance is a biotechnology company specializing in aesthetics and skincare, recognized for its innovative products such as DAXXIFY, the first peptide-formulated neuromodulator, and the SkinPen microneedling device, positioning itself as a leader in the market.
- In the past year, Revance has made significant strides, including the distribution of over 1 million SkinPen treatment kits since January 2025, the launch of the StriVectin Barrier Restore+ Collection in February 2026, and the appointment of Steve Kreider as EVP, Chief Revenue Officer for Aesthetics and Therapeutics in January 2026.
- Revance has strengthened its portfolio through the acquisition of Crown Laboratories, uniting aesthetics and skincare under one brand and expanding its global presence, while also collaborating with Teoxane to offer the RHA Dynamic Volume filler.
- The ideal buyer for Revance includes healthcare providers and aesthetic practitioners seeking cutting-edge solutions for patient treatments, as the company addresses the growing demand for effective and innovative aesthetic therapies in a competitive market.
Healthcare functions—including clinical, medical affairs, and regulatory roles—form the largest group at 107 employees, underscoring the company’s scientific focus. Sales and Support follows closely with 101 team members who help bring products to market and assist customers. Engineering employs 81 specialists, while Marketing and Product teams total 45 employees, reflecting an emphasis on both innovation and go-to-market execution. Business Management, Finance and Administration, Operations, Consulting, and Quality collectively account for the remaining headcount, illustrating a diversified mix of corporate and technical expertise.
Revance’s workforce is distributed across more than twenty sites. The largest concentration is in San Francisco, home to 116 employees, while the Nashville office hosts 59 team members. Additional hubs include Los Angeles, Dallas, New York City, San Diego, Chicago, Houston, and Denver, each with a modest share of staff. A sizable segment—303 employees—work from various other locations, highlighting the company’s nationwide presence and flexible staffing model.
